YOUR CART
Hey, It feels so Light!
There is nothing in your bag, let's add some products.
YOUR WISHLIST
Your wishlist is empty!
Start adding products to your wishlist.



Kerashine-MF Aqua Solution – 60 ml | For Hair Regrowth in Men
4.5
(524 Reviews)
MRP:
₹1069
(incl. of all taxes.)


Get it by Mon, Aug 18
Available offers
Get free shipping on purchase of Rs. 2,000 or above
Auto-applied at checkout.
Order within 6 hrs 10 mins to get it by Monday, August 18*
Product Details
Kerashine-MF Aqua Solution is a clinically formulated treatment for hair loss in men, combining Minoxidil (5%) and Finasteride (0.1%). This dual-action solution helps boost blood flow to the scalp, stimulate hair follicles, and reduce hormone-driven hair loss—leading to thicker, fuller hair regrowth over time.
Recommended for hereditary hair thinning or baldness, particularly at the crown, this treatment is most effective with regular, long-term use.
How to Use:
Apply directly to a clean, dry scalp as advised by your doctor
Wash hands before and after application
Avoid shampooing or using a hairdryer for at least 4 hours after application
For external use only; avoid contact with eyes or broken skin
Use consistently for visible results, which may take a few months
Key Benefits:
Promotes hair regrowth and increases hair density
Helps prevent further hair thinning or balding
Improves scalp blood circulation
Blocks hormone that triggers hair loss
Easy-to-apply topical solution
Important Notes:
For men only; not for use by women or children
Do not exceed the recommended dose
Temporary hair shedding may occur initially—this is normal
Consult your doctor if no improvement is seen after 4–6 months
Storage:
Store below 25°C in a cool, dry place. Keep out of reach of children.
Product Specifications
Key Ingredients
For better results, don't miss:
Customer Reviews

100% Authentic
Genuine Products Guaranteed

Free Delivery
Orders Over INR 2,000

Dermatologist Recommended
Expert Consultations Available

Easy Returns
Effortless Returns and Refunds
We Are in the News






